CAS RN: 640-79-9

Glycochenodeoxycholic Acid

Product Availability

Choose a grade to view its available package options.

6 package records6 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250419 100mg In stock Shanghai, Tianjin, Chengdu Inquiry
Batchno.20251024 1g In stock Shanghai Inquiry
Batchno.20251204 250mg In stock Shanghai Inquiry
Batchno.20250416 5g In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250417 1g In stock Inquiry
Batchno.20250626 250mg In stock Inquiry
  • Product code: starshine_CAS640-79-9
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

640-79-9 / 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid

Standard CAS: 640-79-9 Multi CAS: Yes

Basic Information

CAS
640-79-9
Multi CAS
Yes
Molecular Formula
C26H43NO5
Molecular Weight
449.600000
Exact Mass
449.314123
InChI
InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1
InChIKey
GHCZAUBVMUEKKP-GYPHWSFCSA-N

Physical Properties

Physical Description
Solid
State
Solid

Computed Properties

Structural Parameters

Heavy atom count
32
Fraction Csp3
0.92
Rotatable bonds
6
H-bond acceptors
4
H-bond donors
4
Molar refractivity
121.66
TPSA
106.86

LogP / Solubility

WLOGP
3.59
MLOGP
3.19
XLogP3
4.3
Consensus LogP
3.69
Log S (ESOL)
-4.5
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.84
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-6.29
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.91

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
8

Get In Touch

Contact Us